Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Indraprastha Medical's FCF Yield % or its related term are showing as below:
BOM:532150'
s FCF Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 3.12
Current: 3.12
During the past 13 years, the highest FCF Yield % of Indraprastha Medical was 3.12%. The lowest was 0.00%. And the median was 0.00%.
BOM:532150's FCF Yield % is ranked better than 56.39% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.87
vs BOM:532150: 3.12
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Indraprastha Medical FCF Yield % Related Terms
Indraprastha Medical FCF Yield % Historical Data
* Premium members only.
The historical data trend for Indraprastha Medical's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532150 vs HCA, THC, DVA: FCF Yield % Comparison
For the Medical Care Facilities subindustry, Indraprastha Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indraprastha Medical FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Indraprastha Medical's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indraprastha Medical (BOM:532150) has a FCF Yield % of 3.12 as of Aug. 13, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Indraprastha Medical and its competitors. According to the industry distribution chart, Indraprastha Medical ranks #297 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 43.6%.
Is Indraprastha Medical's FCF Yield % too high?
Indraprastha Medical's current FCF Yield % is 3.12. The Healthcare Providers & Services industry median FCF Yield % is 1.87. Indraprastha Medical's value of 3.12 is 66.8% above this industry median. Based on the distribution chart, Indraprastha Medical ranks #297 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Indraprastha Medical has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Indraprastha Medical's FCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Indraprastha Medical ranks #297 out of 681 companies for FCF Yield %. This puts Indraprastha Medical in the upper half of its industry. The industry median FCF Yield % is 1.87. Indraprastha Medical's value of 3.12 is 66.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.87, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indraprastha Medical's current FCF Yield % of 3.12 is 66.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Indraprastha Medical and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indraprastha Medical's current FCF Yield % is 3.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indraprastha Medical stock overvalued right now?
Based on GuruFocus' analysis, Indraprastha Medical (BOM:532150) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.21, compared to a current price of ₹376.95 — trading 10.3% below its estimated fair value. The current FCF Yield % is 3.12 and 66.8% above the Healthcare Providers & Services industry median of 1.87. Indraprastha Medical's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Indraprastha Medical (BOM:532150), the current FCF Yield % is 3.12 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indraprastha Medical (BOM:532150) Overvalued in 2026?
Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued.
The current stock price of ₹376.95 is trading 10.3% below its estimated GF Value™ of ₹420.21.
GuruFocus considers Indraprastha Medical to be Modestly Undervalued.
Key valuation signals for BOM:532150:
FCF Yield %: 3.12
GF Value™: ₹420.21 vs. price of ₹376.95 (10.3% below fair value)
Industry Position: 66.8% above the Healthcare Providers & Services median (#297 of 681)
No single metric tells the full story. See the BOM:532150 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
81GF Score
Get the complete analysis for BOM:532150
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532150 has been successfully added to your 
